Literature DB >> 410580

The construction of a pharmacokinetic model for the disposition of polychlorinated biphenyls in the rat.

M W Anderson, T E Eling, R J Lutz, R L Dedrick, H B Matthews.   

Abstract

The construction of a preliminary pharmacokinetic model for the distribution, long-term storage sites, excretion, and metabolism of selected polychlorinated biphenyls (PCBs) in the rat is described. Following intravenous administration of radioactive PCBs, several metaboiltes of each PCB isomer were detected in urine or feces, excreted primarily as glucuronide conjugates. The relative and absolute amount of metabolites excreted depended upon the degree of chlorination and the position of the chlorine on the biphenyl molecule. Concerning long-term storage sties, an unanticipated finding was accumulation in skin, as revealed by the particularly long half-life of the 6-CB isomer in skin. A flow diagram of the model is presented, as are the differential equations, solved by computer for a given dose schedule, for the individual mass balances on parent and metabolite in each of the compartments that represent the organs or regions in which the concentration is assumed to be uniform. Low-level, long-term doses of PCBs produce a variety of toxicologic symptoms which appear only after long-time exposure. Such models should be useful in explaining and predicting the toxicities induced by exposure to PCBs and similar contaminants and the time required to reach a steady-state tissue concentration for given long-term doses.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 410580     DOI: 10.1002/cpt1977225part2765

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Distribution and excretion of 2,2', 4,4',6-pentachlorobiphenyl in the rat.

Authors:  G R Felt; W F Mueller; F Coulston; F Korte
Journal:  Bull Environ Contam Toxicol       Date:  1979-07       Impact factor: 2.151

Review 2.  Physiologically based pharmacokinetic models for anticancer drugs.

Authors:  H S Chen; J F Gross
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Clearance of polychlorinated biphenyl atropisomers is enantioselective in female C57Bl/6 mice.

Authors:  Izabela Kania-Korwel; Mohammed H M E El-Komy; Peter Veng-Pedersen; Hans-Joachim Lehmler
Journal:  Environ Sci Technol       Date:  2010-04-15       Impact factor: 9.028

4.  Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.

Authors:  M Gibaldi; J R Koup
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Inhalation dosimetry modeling with decamethylcyclopentasiloxane in rats and humans.

Authors:  Micaela B Reddy; Ivan D Dobrev; Debra A McNett; Joseph M Tobin; Mark J Utell; Paul E Morrow; Jeanne Y Domoradzki; Kathleen P Plotzke; Melvin E Andersen
Journal:  Toxicol Sci       Date:  2008-06-26       Impact factor: 4.849

6.  Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptors.

Authors:  Deena M Walker; Bailey A Kermath; Michael J Woller; Andrea C Gore
Journal:  Endocrinology       Date:  2013-04-16       Impact factor: 4.736

7.  Accumulation and persistence of individual polychlorinated biphenyl congeners in liver, blood, and adipose tissue of rats following dietary exposure to Aroclor 1254.

Authors:  R W Nims; S D Fox; H J Issaq; R A Lubet
Journal:  Arch Environ Contam Toxicol       Date:  1994-11       Impact factor: 2.804

8.  Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies.

Authors:  Marc-André Verner; Michel Charbonneau; Lizbeth López-Carrillo; Sami Haddad
Journal:  Environ Health Perspect       Date:  2008-07       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.